Organon (OGN) Liabilities and Shareholders Equity (2020 - 2026)

Organon (OGN) has reported Liabilities and Shareholders Equity for 7 consecutive years, with $13.0 billion the latest figure, recorded in Q1 2026.

• In Q1 2026, Liabilities and Shareholders Equity fell 1.22% year-over-year to $13.0 billion; the TTM figure through Mar 2026 stood at $52.9 billion (up 3.42% YoY), while the FY2025 annual figure was $12.9 billion, down 1.79% from the prior year.
• Liabilities and Shareholders Equity came in at $13.0 billion for Q1 2026 at Organon, up from $12.9 billion in the prior quarter.
• The five-year high for Liabilities and Shareholders Equity was $13.6 billion in Q3 2025, with the low at $10.4 billion in Q3 2022.
• Average Liabilities and Shareholders Equity over 5 years is $12.0 billion, with a median of $12.1 billion recorded in 2023.
• Across the five-year window, Liabilities and Shareholders Equity decreased 7.92% in 2022 and increased 15.8% in 2024, its largest moves.
• Year by year, Liabilities and Shareholders Equity stood at $11.0 billion in 2022, then climbed by 10.07% to $12.1 billion in 2023, then gained by 8.65% to $13.1 billion in 2024, then dropped by 1.79% to $12.9 billion in 2025, then advanced by 1.0% to $13.0 billion in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $13.0 billion, $12.9 billion, and $13.6 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.